Geode Capital Management
TAK icon

Geode Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Geode Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-53,740
Closed -$732K – 5023
2021
Q4 		$732K Buy
53,740
+23,176
+76% +$325K ﹤0.01% 3857
2021
Q3 		$500K Sell
30,564
-10,193
-25% -$171K ﹤0.01% 4026
2021
Q2 		$685K Sell
40,757
-32,204
-44% -$548K ﹤0.01% 3789
2021
Q1 		$1.33M Buy
72,961
+38,258
+110% +$688K ﹤0.01% 3440
2020
Q4 		$631K Sell
34,703
-15,931
-31% -$280K ﹤0.01% 3516
2020
Q3 		$903K Buy
50,634
+1,892
+4% +$34.5K ﹤0.01% 3251
2020
Q2 		$873K Buy
48,742
+16,877
+53% +$303K ﹤0.01% 3185
2020
Q1 		$483K Sell
31,865
-31,109
-49% -$564K ﹤0.01% 3285
2019
Q4 		$1.24M Buy
62,974
+16,710
+36% +$320K ﹤0.01% 3203
2019
Q3 		$795K Buy
46,264
+8,238
+22% +$142K ﹤0.01% 3312
2019
Q2 		$673K Sell
38,026
-40,969
-52% -$746K ﹤0.01% 3357
2019
Q1 		$1.61M Buy
78,995
+31,672
+67% +$637K ﹤0.01% 2977
2018
Q4 		$795K Buy
+47,323
New +$799K ﹤0.01% 3200

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management's TAK Position: Q1 2022 in Review

Geode Capital Management sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 53,740 shares — an estimated $732K sold.

Geode Capital Management first reported a position in TAK in Q4 2018 and held it in 13 quarters. The position peaked at $1.61M in Q1 2019. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Geode Capital Management reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Geode Capital Management sold 53,740 Takeda Pharmaceutical shares in Q1 2022, an estimated $732K.
  • Geode Capital Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 13 quarters.
  • Geode Capital Management's Takeda Pharmaceutical position peaked at $1.61M in Q1 2019.
  • 288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.